Sava Infond d.o.o. Decreases Stock Position in UnitedHealth Group Incorporated $UNH

Key Points

• Sava Infond d.o.o. has reduced its stake in UnitedHealth Group by 13.2%, now holding 5,600 shares valued at approximately $1.75 million.
• Analysts are mixed on UnitedHealth Group, with ratings ranging from a "strong sell" to "overweight," and a consensus rating of "Hold" with an average price target of $358.95.
• The company recently declared a quarterly dividend of $2.21 per share, resulting in an annualized yield of 2.5% with a payout ratio of 38.30%.

Sava Infond d.o.o. cut its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 13.2% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 5,600 shares of the healthcare conglomerate's stock after selling 850 shares during the quarter. Sava Infond d.o.o.'s holdings in UnitedHealth Group were worth $1,747,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently added to or reduced their stakes in the stock. Retirement Planning Group LLC increased its holdings in UnitedHealth Group by 5.1% in the 1st quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate's stock valued at $225,000 after buying an additional 21 shares during the period. Net Worth Advisory Group increased its holdings in UnitedHealth Group by 0.6% in the 1st quarter. Net Worth Advisory Group now owns 3,642 shares of the healthcare conglomerate's stock valued at $1,907,000 after buying an additional 21 shares during the period. Bensler LLC increased its holdings in UnitedHealth Group by 0.3% in the 1st quarter. Bensler LLC now owns 6,945 shares of the healthcare conglomerate's stock valued at $3,637,000 after buying an additional 22 shares during the period. Lakeridge Wealth Management LLC increased its holdings in UnitedHealth Group by 5.8% in the 1st quarter. Lakeridge Wealth Management LLC now owns 420 shares of the healthcare conglomerate's stock valued at $220,000 after buying an additional 23 shares during the period. Finally, Broadway Wealth Solutions Inc. increased its holdings in UnitedHealth Group by 2.1% in the 1st quarter. Broadway Wealth Solutions Inc. now owns 1,151 shares of the healthcare conglomerate's stock valued at $603,000 after buying an additional 24 shares during the period. 87.86% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts have recently commented on the stock. Baird R W downgraded shares of UnitedHealth Group from a "hold" rating to a "strong sell" rating in a research note on Thursday, July 31st. KeyCorp reduced their target price on shares of UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating on the stock in a research note on Wednesday, July 30th. Bank of America boosted their target price on shares of UnitedHealth Group from $290.00 to $325.00 and gave the company a "neutral" rating in a research note on Monday, August 18th. Barclays boosted their target price on shares of UnitedHealth Group from $337.00 to $352.00 and gave the company an "overweight" rating in a research note on Thursday, September 4th. Finally, Piper Sandler cut their price target on UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating for the company in a report on Wednesday, July 30th. Sixteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and four have given a Sell rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $358.95.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $360.17 on Friday. The stock has a market capitalization of $326.20 billion, a price-to-earnings ratio of 15.61, a P/E/G ratio of 2.30 and a beta of 0.47. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock has a 50-day simple moving average of $307.84 and a 200 day simple moving average of $355.58.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business's revenue for the quarter was up 12.9% compared to the same quarter last year. During the same period in the prior year, the firm posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.5%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group's payout ratio is currently 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.